| scholarly article | Q13442814 |
| P2093 | author name string | Connie Sánchez | |
| Fenghua Chen | |||
| Ove Wiborg | |||
| Per Plenge | |||
| Mads Breum Larsen | |||
| Henrik Amtoft Neubauer | |||
| P2860 | cites work | Pharmacological profile of antidepressants and related compounds at human monoamine transporters | Q28267324 |
| Oligomerization of serotonin transporter and its functional consequences | Q28576047 | ||
| Glycosyl modification facilitates homo- and hetero-oligomerization of the serotonin transporter. A specific role for sialic acid residues | Q28577005 | ||
| Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity. | Q32062587 | ||
| Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters | Q34574701 | ||
| Placental biogenic amine transporters: cloning and expression | Q36854331 | ||
| Cloning and expression of a functional serotonin transporter from rat brain | Q38332277 | ||
| Cloning and expression of the mouse serotonin transporter | Q39758098 | ||
| Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants | Q40938811 | ||
| The membrane-bound rat serotonin transporter, SERT1, is an oligomeric protein | Q41166656 | ||
| Evidence for the existence of at least two different binding sites for 5HT-reuptake inhibitors within the 5HT-reuptake system from human platelets | Q41337255 | ||
| Species-scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high-affinity recognition of antidepressants | Q43777358 | ||
| Molecular cloning, expression and characterization of a bovine serotonin transporter | Q47946859 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | serotonin | Q167934 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 21-28 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Characterization of an allosteric citalopram-binding site at the serotonin transporter. | |
| P478 | volume | 92 |
| Q33718185 | A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike? |
| Q35607595 | A fluorescence displacement assay for antidepressant drug discovery based on ligand-conjugated quantum dots |
| Q91184064 | Analytical methodologies for the enantiodetermination of citalopram and its metabolites |
| Q46798751 | Anxiolytic and panicolytic effects of escitalopram in the elevated T-maze |
| Q40014294 | Characterisation of the zebrafish serotonin transporter functionally links TM10 to the ligand binding site |
| Q28583883 | Chronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporter-independent action of this antidepressant compound |
| Q91857105 | Clickable photoaffinity ligands for the human serotonin transporter based on the selective serotonin reuptake inhibitor (S)-citalopram |
| Q34664591 | Comparative efficacy of escitalopram in the treatment of major depressive disorder |
| Q37490255 | Design and synthesis of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (citalopram) analogues as novel probes for the serotonin transporter S1 and S2 binding sites. |
| Q26781605 | Designing modulators of monoamine transporters using virtual screening techniques |
| Q40068020 | Different Binding Modes of Small and Large Binders of GAT1. |
| Q42116436 | Different effects of selective dopamine uptake inhibitors, GBR 12909 and WIN 35428, on HIV-1 Tat toxicity in rat fetal midbrain neurons |
| Q30582295 | Disruption of aminergic signalling reveals novel compounds with distinct inhibitory effects on mosquito reproduction, locomotor function and survival |
| Q48114156 | Escitalopram Ameliorates Forskolin-Induced Tau Hyperphosphorylation in HEK239/tau441 Cells |
| Q36479510 | Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability. |
| Q37928965 | Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter--a review of current understanding of its mechanism of action |
| Q34072466 | Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression |
| Q37784204 | Escitalopram: a review of its use in the management of major depressive disorder in adults |
| Q36304817 | Escitalopram: a review of its use in the management of major depressive disorder. |
| Q89802291 | GluD1 knockout mice with a pure C57BL/6N background show impaired fear memory, social interaction, and enhanced depressive-like behavior |
| Q36494042 | In vivo investigation of escitalopram's allosteric site on the serotonin transporter |
| Q53532774 | MS Binding Assays for the Three Monoamine Transporters Using the Triple Reuptake Inhibitor (1R,3S)-Indatraline as Native Marker. |
| Q28554731 | Mapping Cholesterol Interaction Sites on Serotonin Transporter through Coarse-Grained Molecular Dynamics |
| Q37064777 | Nanopharmacological Force Sensing to Reveal Allosteric Coupling in Transporter Binding Sites |
| Q34203601 | Pharmaceuticals as neuroendocrine disruptors: lessons learned from fish on Prozac |
| Q28476265 | Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters |
| Q46426130 | Revisiting pharmacological actions of antidepressants: the example of escitalopram |
| Q90284315 | Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport |
| Q46944570 | Spotlight on escitalopram in the management of major depressive disorder. |
| Q36407799 | Steric hindrance mutagenesis in the conserved extracellular vestibule impedes allosteric binding of antidepressants to the serotonin transporter |
| Q49594975 | Structural basis for recognition of diverse antidepressants by the human serotonin transporter |
| Q90293420 | Structure and Gating Dynamics of Na+/Cl- Coupled Neurotransmitter Transporters |
| Q38572969 | Structure-activity relationship studies of citalopram derivatives: examining substituents conferring selectivity for the allosteric site in the 5-HT transporter |
| Q36926340 | Studies of the biogenic amine transporters. 12. Identification of novel partial inhibitors of amphetamine-induced dopamine release. |
| Q24655326 | Studies of the biogenic amine transporters. 13. Identification of "agonist" and "antagonist" allosteric modulators of amphetamine-induced dopamine release |
| Q28258698 | The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram |
| Q42955459 | What one hand giveth the other taketh away: some unpredicted effects of enantiomers in psychopharmacology |
Search more.